Establishment Labs Begins Trading on the NASDAQ

Medical Device Investing

Establishment Labs Holdings (NASDAQ:ESTA) has announced that its common stock has begun trading on the NASDAQ. As quoted in the press release: Establishment Labs is a global medical technology company focused on breast aesthetics and reconstruction technologies. Founder and Chief Executive Officer Juan José Chacón-Quirós, joined by members of the company’s management team and family, …

Establishment Labs Holdings (NASDAQ:ESTA) has announced that its common stock has begun trading on the NASDAQ.

As quoted in the press release:

Establishment Labs is a global medical technology company focused on breast aesthetics and reconstruction technologies.
Founder and Chief Executive Officer Juan José Chacón-Quirós, joined by members of the company’s management team and family, celebrated the company’s first day of trading by visiting the exchange.
“Today’s listing on Nasdaq represents a significant milestone for Establishment Labs and our shareholders,” said Mr. Chacón-Quirós. “It’s an honor to be the first company headquartered in Costa Rica to be listed on a major stock exchange in the United States.”
“We welcome Establishment Labs to the Nasdaq family, and look forward to supporting their continued success,” said Joe Brantuk, Vice President of Nasdaq. “Establishment Labs continuously works to improve patient safety and aesthetic outcomes while simultaneously working towards its entry into the U.S. market.”

Click here to read the full press release.

medical technology Medical Device Investing